Evaluation of new anti-infective drugs for the treatment of acute infectious diarrhea

Clinical Infectious Diseases

Volumn 15, Issue , 1992, Pages S228-S235

  DuPont, Herbert L ^a,b,c,d,e   Cooperstock, Michael ^a,b,c,d,e   Corrado, Michael L ^a,b,c,d,e   Fekety, Robert ^a,b,c,d,e   Murray, Donna Morgan ^a,b,c,d,e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c Robert Wood Johnson P   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; BICOZAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FURAZOLIDONE; MECILLINAM; QUINOLONE DERIVATIVE; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ACUTE DIARRHEA; ANTIMICROBIAL THERAPY; CLINICAL TRIAL; DRUG SCREENING; FECES ANALYSIS; HUMAN; INFANT; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REHYDRATION; REVIEW; STANDARD; TRAVELLER DIARRHEA;

ACUTE DISEASE; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CLINICAL PROTOCOLS; CLINICAL TRIALS; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; DIARRHEA; HUMAN; RESEARCH DESIGN; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026476206     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clind/15.Supplement_1.S228     Document Type: Article

References (38)

1. Harris JC, DuPont HL, Hornick RB. Fecal leukocytes in diarrheal illness. Ann Intern Med 1972;76:697-703
2. DuPont HL, Ericsson CD, Robinson A, Johnson PC. Current problems in antimicrobial therapy for bacterial enteric infection. Am J Med 1987;82(suppl 4A):324-8
3. Haltalin KC, Nelson JD, Hinton LV, Kusmiesz HT, Sladoje M. Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis. A double-blind study with ampicillin and neomycin. J Pediatr 1968;72:708-20
4. Bassily S, Farid Z, Mikhail JW, Kent DC, Lehman JS Jr. The treatment of Giardia lamblia infection with mepacrine, metronidazole and furazolidone. J Trop Med Hyg 1970;73:15-8
5. Lexomboon U, Mansuwan P, Duangmani C, et al. Clinical evaluation of co-trimoxazole and furazolidone in treatment of shigellosis in children. BMJ 1972;3:23-6
6. Kazemi M, Gumpert TG, Marks MI. A controlled trial comparing sulfamethoxazole-trimethoprim, ampicillin, and no therapy in the treatment of salmonella gastroenteritis in children. J Pediatr 1973; 83:646-50
7. de Olarte DG, Trujillo H, Agudelo N, Nelson JD, Haltalin KC. Treatment of diarrhea in malnourished infants and children: a doubleblind study comparing ampicillin and placebo. Am J Dis Child 1974;127:379-88
8. Craft JC, Murphy T, Nelson JD. Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children. Am J Dis Child 1975;135:164-6
9. Nelson JD, Kusmiesz H, Jackson LH, Woodman E. Trimethoprim-sulfamethoxazole therapy for shigellosis. JAMA 1976;235:1239-43
10. Levi GC, de Avila CA, Amato Neto V. Efficacy of various drugs for treatment of giardiasis. A comparative study. Am J Trop Med Hyg 1977;26:564-5
11. Merson MH, Sack RB, Islam S, et al. Disease due to enterotoxigenic Escherichia coli in Bangladeshi adults: clinical aspects and a controlled trial of tetracycline. J Infect Dis 1980;141:702-11
12. Barada FA Jr, Guerrant RL. Sulfamethoxazole-trimethoprim versus ampicillin in treatment of acute invasive diarrhea in adults. Antimicrob Agents Chemother 1980;17:961-4
13. DuPont HL, Reves RR, Galindo E, Sullivan PS, Wood LV, Mendiola JG. Treatment of travelers’ diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engi J Med 1982; 307:841-4
14. Ericsson CD, DuPont HL, Sullivan P, Galindo E, Evans DG, Evans DJ Jr. Biozamycin, a poorly absorbable antibiotic, effectively treats travelers’ diarrhea. Ann Intern Med 1983;98:20-5
15. DuPont HL, Ericsson CD, Galindo E, et al. Furazolidone versus ampicillin in the treatment of traveler’s diarrhea. Antimicrob Agents Chemother 1984;26:160-3
16. Uylangco C, Santiago L, Pescante M, Menday P, Christensen D. Pivmecillinam, co-trimoxazole and oral mecillinam in gastroenteritis due to Vibrio spp. J Antimicrob Chemother 1984;13:171-5
17. Rogerie F, Ott D, Vandepitte J, Verbist L, et al. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults. Antimicrob Agents Chemother 1986; 29:883-6
18. DuPont HL, Corrado ML, Sabbaj J. Use of norfloxacin in the treatment of acute diarrheal disease. Am J Med 1987;82(suppl 6B):79-83
19. Oberhelman RA, de la Cabada FJ, Garibay EV, Bitsura JAM, DuPont HL. Efficacy of trimethoprim-sulfamethoxazole in treatment of acute diarrhea in a Mexican pediatric population. J Pediatr 1987; 110:9605
20. Pichler HET, Diridl G, Stickler K, Wolf D. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. Am J Med 1987;82(suppl 4A):329-32
21. Ericsson CD, Johnson PC, DuPont HL, Morgan DR, Bitsura JAM, de la Cabada FJ. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers’ diarrhea. A placebo-controlled, randomized trial. Ann Intern Med 1987;106:216-20
22. Kean BH. The diarrhea of travelers to Mexico: summary of five-year study. Ann Intern Med 1963;59:605-14
23. Sack RB. Antimicrobial prophylaxis of travelers’ diarrhea: a selected summary. Rev Infect Dis 1986;8(suppl 2):S160-6
24. DuPont HL, Ericsson CD, Johnson PC, Cabada FJ. Antimicrobial agents in the prevention of travelers’ diarrhea. Rev Infect Dis 1986;8(suppl 2):S 167-71
25. Consensus conference: travelers’ diarrhea. JAMA 1985;253:2700-4
26. Reves RR, Johnson PC, Ericsson CD, DuPont HL. A cost-effectiveness comparison of the use of antimicrobial agents for treatment or prophylaxis of travelers’ diarrhea. Arch Intern Med 1988;148:2421-7
27. Gross RJ, Threlfall EJ, Ward LR, Rowe B. Drug resistance in Shigella dysenieriae, S.flexneri and S. boydii in England and Wales: increasing incidence of resistance to trimethoprim. BMJ 1984;288:784-6
28. Murray BE. Resistance of Shigella, Salmonella and other selected enteric pathogens to antimicrobial agents. Rev Infect Dis 1986; 8(suppl):S 172-81
29. Shungu DL, Weinberg E, Gadebusch HH. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens. Antimicrob Agents Chemother 1983; 23:86-90
30. Carlson JR, Thornton SA, DuPont HL, West AH, Mathewson JJ. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother 1983;24:509-13
31. Goodman LJ, Fleigelman RM, Trenholme GM, Kaplan RL. Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens. Antimicrob Agents Chemother 1984;25:504-6
32. Van der Auwera P, Scorneaux B. In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of β-lactams with clavulanic acid or sulbactam. Antimicrob Agents Chemother 1985;28:37-40
33. Fliegelman RM, Petrak RM, Goodman LJ, Segreti J, Trenholme GM, Kaplan RL. Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrob Agents Chemother 1985;27:429-30
34. DuPont HL, Ericsson CD, Johnson PC, Bitsura JAM, DuPont MW, de la Cabada FJ. Prevention of travelers’ diarrhea by the tablet formulation of bismuth subsalicylate. JAMA 1987;257:1347-50
35. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 1977;35:1-39
36. Anderson S, Auquier A, Hauck WW, Oakes D, Vandaele W, Weisberg HI. Statistical methods for comparative studies. New York: John Wiley & Sons, 1980
37. Drop-outs from clinical trials [editorial]. Lancet 1987;2:892-3
38. Zimmer WJ, Brown JT, Linzer M. Randomization in clinical trials [letter], Ann Intern Med 1987; 107:790